|
Psoriatic arthritis as a distinct disease entity
|
Psoriatic arthritis (PsA) is a chronic systemic inflammatory disease characterized by joint inflammation associated with cutaneous psoriasis. PsA may be progressive, destructive and deforming. Its exact prevalence is unknown, but estimates vary from 0.3% to 1% of the population.[1] Both the skin lesion and the joint involvement may have deleterious effects on affected individuals. For many years the attention on PsA has been less than that on other arthropathies. The management and assessment...
Related newspaper, magazine, and journal articles from HighBeam Research
|
|
Psoriatic arthritis as a distinct disease entity
Journal of Postgraduate Medicine
; Psoriatic arthritis (PsA) is a chronic systemic inflammatory disease characterized by joint inflammation associated with cutaneous psoriasis. PsA may be progressive, destructive and deforming. Its exact prevalence is unknown, but estimates vary from 0.3% to 1% of the population.[1] Both the skin
|
|
Data pegs psoriatic arthritis prevalence at 1 million
Dermatology Times
; Clinical Dermatology Patients say disease has moderate to large impact on lives, including sleep problems Seattle - A new survey reveals that approximately 1 million Americans have psoriatic arthritis, most of whom say that the disease seriously affects daily living. The survey was conducted for
|
|
One million U.S. adults may suffer from psoriatic arthritis. (Psoriasis News).(Brief Article)
Dermatology Nursing
; ... and DNA Focus Editor. Dermatology Nursing News is a regular feature in Dermatology Nursing. Please send news on professional issues, dermatology issues ... other items of interest to Diana Gorgos, News Editor, c/o Dermatology Nursing, East Holly ...
|
|
In psoriasis, joint pain may not mean psoriatic arthritis.(Rheumatology)
Internal Medicine News
; STOCKHOLM -- It may be wrong to assume that patients with psoriasis and joint pain have psoriatic arthritis, according to data presented at an international conference on psoriasis and psoriatic arthritis by Dr. Elinor Mody. Joint pain in patients with psoriasis does not necessarily equal psoriatic
|
|
|
Dermatologists underestimate psoriatic arthritis incidence
Dermatology Times
; Makes big impact on therapeutic decisions National report-Dermatologists should be more diligent in asking psoriasis patients about symptoms of psoriatic arthritis, says Kenneth Gordon, M.D., associate professor of medicine, Loyola University, Chicago. Many patients with psoriatic arthritis are
|
|
Biologic therapy in psoriasis
Indian Journal of Dermatology, Venereology and Leprology
; Introduction Psoriasis is a common, chronic, disfiguring, inflammatory and proliferative condition of the skin, involving both genetic and environmental factors to play an important role. It is associated with significant morbidity, with 20-30% of the patients having severe disease.[1] Most of the
|
|
|
Drug combo effective in psoriatic arthritis.(Rheumatology)
Internal Medicine News
; CHICAGO -- The combination of methotrexate and alefacept appears to be safe and effective for the treatment of psoriatic arthritis, Mark G. Lebwohl, M.D., said at the 11th International Psoriasis Symposium, sponsored by the Skin Disease Education Foundation. This is the first study to evaluate
|
|
|
Psoriatic arthritis: What dermatologists need to know
Dermatology Times
; Seattle - Dermatologists are usually the first specialists to see patients who have psoriasis and who might have psoriatic arthritis. Their decision about how to treat these patients can impact the cutaneous and arthritic manifestations of the disease. Newer anti-tumor necrosis factor (anti-TNF)
|
|
MTX-alefacept combo may aid psoriatic arthritis.(Dermatologic Therapy)
Skin & Allergy News
; Chicago -- The combination of methotrexate and alefacept appears to be safe and effective for the treatment of psoriatic arthritis, Mark G. Lebwohl, M.D., said at the 11th International Psoriasis Symposium, sponsored by the Skin Disease Education Foundation. This is the first study aimed at
|
|
Psoriasis Group Hails FDA Approval of Remicade for Psoriatic Arthritis
U.S. Newswire
; ... patient advocacy group, responded today to news that the U.S. Food and Drug Administration ... Remicade for psoriatic arthritis is great news for psoriatic arthritis patients," said ... campaign at http://www.psorcurenow.org. "The news of Remicade's approval is particularly ...
|